think the statement if marketed is telling, because as most are focusing on viraleze this is signification for other respiratory (or is it limited to just that) viral infection.
it could be that because antibotic become less affective or not at all (as a relative is in hospital where they are not working at all, and they have not idea what bacteria) that antivirals of the nature can combative against bacterial infections. there is research around that there are both pros and cons. the positive was that bacterium get confused if i can call it that and stop reproducing the downside as i can understand is that the bacteria might reinforce .
dyor
think the statement if marketed is telling, because as most are...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109616 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |